Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Critical Care
Published in: Critical Care 4/2010

Open Access 01-08-2010 | Research

A systematic review of randomized controlled trials exploring the effect of immunomodulative interventions on infection, organ failure, and mortality in trauma patients

Authors: Nicole E Spruijt, Tjaakje Visser, Luke PH Leenen

Published in: Critical Care | Issue 4/2010

Login to get access

Abstract

Introduction

Following trauma, patients may suffer an overwhelming pro-inflammatory response and immune paralysis resulting in infection and multiple organ failure (MOF). Various potentially immunomodulative interventions have been tested. The objective of this study is to systematically review the randomized controlled trials (RCTs) that investigate the effect of potentially immunomodulative interventions in comparison to a placebo or standard therapy on infection, MOF, and mortality in trauma patients.

Methods

A computerized search of MEDLINE, the Cochrane CENTRAL Register of Controlled Trials, and EMBASE yielded 502 studies, of which 18 unique RCTs were deemed relevant for this study. The methodological quality of these RCTs was assessed using a critical appraisal checklist for therapy articles from the Centre for Evidence Based Medicine. The effects of the test interventions on infection, MOF, and mortality rates and inflammatory parameters relative to the controls were recorded.

Results

In most studies, the inflammatory parameters differed significantly between the test and control groups. However, significant changes in infection, MOF, and mortality rates were only measured in studies testing immunoglobulin, IFN-γ, and glucan.

Conclusions

Based on level 1b and 2b studies, administration of immunoglobulin, IFN-γ, or glucan have shown the most promising results to improve the outcome of trauma patients.
Appendix
Available only for authorised users
Literature
1.
Peden M, McGee K, Krug E: Injury: A leading cause of the global burden of disease, 2000. Geneva, Switzerland: World Health Organization; 2002.
2.
Teixeira PG, Inaba K, Hadjizacharia P, Brown C, Salim A, Rhee P, Browder T, Noguchi TT, Demetriades D: Preventable or potentially preventable mortality at a mature trauma center. J Trauma 2007, 63: 1338-1346. discussion 1346-1337 10.1097/TA.0b013e31815078aeCrossRefPubMed
3.
Moore FA, Sauaia A, Moore EE, Haenel JB, Burch JM, Lezotte DC: Postinjury multiple organ failure: a bimodal phenomenon. J Trauma 1996, 40: 501-510. discussion 510-502 10.1097/00005373-199604000-00001CrossRefPubMed
4.
Bone RC: Sir Isaac Newton, sepsis, SIRS, and CARS. Crit Care Med 1996, 24: 1125-1128. 10.1097/00003246-199607000-00010CrossRefPubMed
5.
6.
Keel M, Trentz O: Pathophysiology of polytrauma. Injury 2005, 36: 691-709. 10.1016/j.injury.2004.12.037CrossRefPubMed
7.
Moore EE, Moore FA, Harken AH, Johnson JL, Ciesla D, Banerjee A: The two-event construct of postinjury multiple organ failure. Shock 2005, 24: 71-74. 10.1097/01.shk.0000191336.01036.feCrossRefPubMed
8.
Montejo JC, Zarazaga A, Lopez-Martinez J, Urrutia G, Roque M, Blesa AL, Celaya S, Conejero R, Galban C, Garcia de Lorenzo A, Grau T, Mesejo A, Ortiz-Leyba C, Planas M, Ordonez J, Jimenez FJ: Immunonutrition in the intensive care unit. A systematic review and consensus statement. Clin Nutr 2003, 22: 221-233. 10.1016/S0261-5614(03)00007-4CrossRefPubMed
9.
10.
11.
Bauer M, Redl H, Mari I: Prophylactic veno-venous haemofiltration and inflammatory response to multiple trauma. International Journal of Intensive Care 2001, 8: 194-199.
12.
Rommelsheim K: Preventive use of Pentaglobin in intensive care treatment of trauma patients. Anasth Intensivther Notfallmed 1989, 24: 162-166. 10.1055/s-2007-1001544CrossRefPubMed
13.
Dries DJ, Jurkovich GJ, Maier RV, Clemmer TP, Struve SN, Weigelt JA, Stanford GG, Herr DL, Champion HR, Lewis FR, et al.: Effect of interferon gamma on infection-related death in patients with severe injuries. A randomized, double-blind, placebo-controlled trial. Arch Surg 1994, 129: 1031-1041. discussion 1042CrossRefPubMed
14.
Miller CL, Lim RC: Dextran as a modulator of immune and coagulation activities in trauma patients. J Surg Res 1985, 39: 183-191. 10.1016/0022-4804(85)90141-6CrossRefPubMed
15.
Vassar MJ, Fletcher MP, Perry CA, Holcroft JW: Evaluation of prostaglandin E1 for prevention of respiratory failure in high risk trauma patients: a prospective clinical trial and correlation with plasma suppressive factors for neutrophil activation. Prostaglandins Leukot Essent Fatty Acids 1991, 44: 223-231. 10.1016/0952-3278(91)90021-VCrossRefPubMed
16.
Seekamp A, Van Griensven M, Dhondt E, Diefenbeck M, Demeyer I, Vundelinckx G, Haas N, Schaechinger U, Wolowicka L, Rammelt S, Stroobants J, Marzi I, Brambrink AM, Dziurdzik P, Gasiorowski J, Redl H, Beckert M, Khan-Boluki J: The effect of anti-L-selectin (aselizumab) in multiple traumatized patients - Results of a phase II clinical trial. Crit Care Med 2004, 32: 2021-2028. 10.1097/01.CCM.0000142396.59236.F3CrossRefPubMed
17.
Seekamp A, Van Griensven M, Rusu C, Konig J, Khan-Boluki J, Redl H: The effect of anti-L-selectin (Aselizumab) on the posttraumatic inflammatory response in multiply traumatized patients. European Journal of Trauma 2005, 31: 557-567. 10.1007/s00068-005-1066-4CrossRef
18.
Dries DJ, Walenga JM, Hoppensteadt D, Fareed J: Molecular markers of hemostatic activation and inflammation following major injury: effect of therapy with IFN-gamma. J Interferon Cytokine Res 1998, 18: 327-335. 10.1089/jir.1998.18.327CrossRefPubMed
19.
Bulger EM, Jurkovich GJ, Nathens AB, Copass MK, Hanson S, Cooper C, Liu PY, Neff M, Awan AB, Warner K, Maier RV: Hypertonic resuscitation of hypovolemic shock after blunt trauma: a randomized controlled trial. Arch Surg 2008, 143: 139-148. discussion 149 10.1001/archsurg.2007.41CrossRefPubMed
20.
Glinz W, Grob PJ, Nydegger UE, Ricklin T, Stamm F, Stoffel D, Lasance A: Polyvalent immunoglobulins for prophylaxis of bacterial infections in patients following multiple trauma. A randomized, placebo-controlled study. Intensive Care Med 1985, 11: 288-294. 10.1007/BF00273538CrossRefPubMed
21.
Nathens AB, Nester TA, Rubenfeld GD, Nirula R, Gernsheimer TB: The effects of leukoreduced blood transfusion on infection risk following injury: a randomized controlled trial. Shock 2006, 26: 342-347. 10.1097/01.shk.0000228171.32587.a1CrossRefPubMed
22.
Polk HC Jr, Cheadle WG, Livingston DH, Rodriguez JL, Starko KM, Izu AE, Jaffe HS, Sonnenfeld G: A randomized prospective clinical trial to determine the efficacy of interferon-gamma in severely injured patients. Am J Surg 1992, 163: 191-196. 10.1016/0002-9610(92)90099-DCrossRefPubMed
23.
Rhee P, Morris J, Durham R, Hauser C, Cipolle M, Wilson R, Luchette F, McSwain N, Miller R: Recombinant humanized monoclonal antibody against CD18 (rhuMAb CD18) in traumatic hemorrhagic shock: results of a phase II clinical trial. Traumatic Shock Group. J Trauma 2000, 49: 611-619. discussion 619-620 10.1097/00005373-200010000-00007CrossRefPubMed
24.
Croce MA, Fabian TC, Patton JH Jr, Melton SM, Moore M, Trenthem LL: Partial liquid ventilation decreases the inflammatory response in the alveolar environment of trauma patients. J Trauma 1998, 45: 273-280. discussion 280-272 10.1097/00005373-199808000-00012CrossRefPubMed
25.
Marzi I, Buhren V, Schuttler A, Trentz O: Value of superoxide dismutase for prevention of multiple organ failure after multiple trauma. J Trauma 1993, 35: 110-119. discussion 119-120 10.1097/00005373-199307000-00018CrossRefPubMed
26.
Nakos G, Malamou-Mitsi VD, Lachana A, Karassavoglou A, Kitsiouli E, Agnandi N, Lekka ME: Immunoparalysis in patients with severe trauma and the effect of inhaled interferon-gamma. Crit Care Med 2002, 30: 1488-1494. 10.1097/00003246-200207000-00015CrossRefPubMed
27.
Rizoli SB, Rhind SG, Shek PN, Inaba K, Filips D, Tien H, Brenneman F, Rotstein O: The immunomodulatory effects of hypertonic saline resuscitation in patients sustaining traumatic hemorrhagic shock: a randomized, controlled, double-blinded trial. Ann Surg 2006, 243: 47-57. 10.1097/01.sla.0000193608.93127.b1PubMedCentralCrossRefPubMed
28.
Waydhas C, Nast-Kolb D, Gippner-Steppert C, Trupka A, Pfundstein C, Schweiberer L, Jochum M: High-dose antithrombin III treatment of severely injured patients: results of a prospective study. J Trauma 1998, 45: 931-940. 10.1097/00005373-199811000-00015CrossRefPubMed
29.
Browder W, Williams D, Pretus H, Olivero G, Enrichens F, Mao P, Franchello A: Beneficial effect of enhanced macrophage function in the trauma patient. Ann Surg 1990, 211: 605-612. discussion 612-603PubMedCentralPubMed
30.
de Felippe Júnior J, da Rocha e Silva Júnior M, Maciel FM, Soares Ade M, Mendes NF: Infection prevention in patients with severe multiple trauma with the immunomodulator beta1–3polyglucose (glucan). Surg Gynecol Obstet 1993, 177: 383-388.PubMed
31.
Livingston DH, Loder PA, Kramer SM, Gibson UE, Polk HC Jr: Interferon gamma administration increases monocyte HLA-DR antigen expression but not endogenous interferon production. Arch Surg 1994, 129: 172-178.CrossRefPubMed
32.
Douzinas EE, Pitaridis MT, Louris G, Andrianakis I, Katsouyanni K, Karmpaliotis D, Economidou J, Sfyras D, Roussos C: Prevention of infection in multiple trauma patients by high-dose intravenous immunoglobulins. Crit Care Med 2000, 28: 8-15. 10.1097/00003246-200001000-00002CrossRefPubMed
33.
Metadata
Title
A systematic review of randomized controlled trials exploring the effect of immunomodulative interventions on infection, organ failure, and mortality in trauma patients
Authors
Nicole E Spruijt
Tjaakje Visser
Luke PH Leenen
Publication date
01-08-2010
Publisher
BioMed Central
Published in
Critical Care / Issue 4/2010
Electronic ISSN: 1364-8535
DOI
https://doi.org/10.1186/cc9218

Other articles of this Issue 4/2010

Critical Care 4/2010 Go to the issue

Commentary

Sepsis-related stress response: known knowns, known unknowns, and unknown unknowns

Commentary

Macrolides and community-acquired pneumonia: is quorum sensing the key?

Research

Central venous oxygen saturation and blood lactate levels during cardiopulmonary bypass are associated with outcome after pediatric cardiac surgery

Commentary

Pulse pressure analysis: to make a long story short

Research

Haemodynamic optimisation improves tissue microvascular flow and oxygenation after major surgery: a randomised controlled trial

Research

Mortality associated with administration of high-dose tranexamic acid and aprotinin in primary open-heart procedures: a retrospective analysis